1.
Emerg Infect Dis
; 27(1)2021 11.
Article
in English
| MEDLINE | ID: covidwho-918101
ABSTRACT
By using paired molecular and antibody testing for severe acute respiratory syndrome coronavirus 2 infection, we determined point prevalence and seroprevalence in Louisiana, USA, during the second phase of reopening. Infections were highly variable by race and ethnicity, work environment, and ZIP code. Census-weighted seroprevalence was 3.6%, and point prevalence was 3.0%.